Diagnosis and management of giant cell tumor of bone in the spine: a brief review

黄稳定; 蔡维泺; 李俊宽

doi:10.19401/j.cnki.1007-3639.2018.08.009

您当前的位置：

首页 >

文章列表页 >

Diagnosis and management of giant cell tumor of bone in the spine: a brief review

更新时间：2026-01-27

- Diagnosis and management of giant cell tumor of bone in the spine: a brief review
- China Oncology Vol. 28, Issue 8, Pages: 614-621(2018)
- 作者机构：
  
  1. 复旦大学附属肿瘤医院骨与软组织外科,上海,200032
  2. 海军92493 部队,辽宁,葫芦岛,125000
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2018.08.009
  CLC： R738.1
- Published Online：14 September 2018，
  
  Published：14 September 2018
- 稿件说明：
移动端阅览
黄稳定,蔡维泺,李俊宽,等. 脊柱骨巨细胞瘤的诊断与治疗进展[J]. 中国癌症杂志, 2018, 28(8): 614-621.

黄稳定, 蔡维泺, 李俊宽. Diagnosis and management of giant cell tumor of bone in the spine: a brief review[J]. China Oncology, 2018, 28(8): 614-621.
黄稳定,蔡维泺,李俊宽,等. 脊柱骨巨细胞瘤的诊断与治疗进展[J]. 中国癌症杂志, 2018, 28(8): 614-621. DOI： 10.19401/j.cnki.1007-3639.2018.08.009.

黄稳定, 蔡维泺, 李俊宽. Diagnosis and management of giant cell tumor of bone in the spine: a brief review[J]. China Oncology, 2018, 28(8): 614-621. DOI： 10.19401/j.cnki.1007-3639.2018.08.009.

摘要

脊柱骨巨细胞瘤（giant cell tumor of bone，GCTB）较为少见，诊断依靠临床、影像和病理三结合原则。脊柱GCTB的治疗难度较大，目前还没有基于循证医学的治疗流程和共识，因而具有很强的挑战性。手术仍然是脊柱GCTB治疗的首选方法，术前选择性动脉栓塞、完整切除肿瘤及术后辅助使用地诺单抗（denosumab）是目前推荐的综合治疗方法。整块切除是脊柱GCTB的理想治疗方式，但手术方法的选择需要遵循个体化原则，根据不同的部位制定不同的手术方案。地诺赛麦对于手术无法完全切除、复发及转移性GCTB的治疗具有一定的优势，术前使用能够有效降低GCTB外科分期，并为整块切除手术创造条件，具有广泛的应用前景。

Abstract

Giant cell tumors of bone (GCTB) in the spine are rarely seen

and the diagnosis relies on clinical presentations

imaging and pathology. The treatment of spinal giant cell tumor is difficult because there is no evidencebased management guidelines and consensus. Surgery is still the first choice for management of the spinal giant cell tumor. Preoperative arterial embolization and complete surgical removal with postoperative denosumab are the recommended treatment methods. En bloc resection is an ideal treatment for spinal giant cell tumors

but surgeons must carefully evaluate patients individually. Denosumab is indicated for patients with unresectable/recurrent/metastatic GCTB. It can effectively reduce the stage of giant GCTB and create conditions for en bloc resection.

关键词

Keywords

references

Views

2841

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Exploring innovative models of surgical treatment for rectal cancer

Progress and future prospects in local and systemic treatment of early breast cancer

Expert consensus on perioperative comprehensive treatment for high risk prostate cancer (2023 edition)

The value of surgery in the patients with de novo stage Ⅳ breast cancer

Influencing factors of cardiovascular adverse events risk in elderly patients with esophageal cancer undergoing video-assisted thoracoscopic surgery and nomogram prediction model construction

Related Author

Dakui LUO

Xinxiang LI

Junjie LI

Anti-Cancer Association China

of Male Reproductive System Oncology Society

Peifen FU

Luyan CHEN

Lixue WANG

Related Institution

Department of Colorectal Surgery, DivisionⅡ, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University

Department of Breast Surgery, Fudan University Shanghai Cancer Center/Fudan University Breast Cancer Institute, Department of Oncology, Shanghai Medical College, Fudan University

Department of Breast Center, The First Affiliated Hospital, Zhejiang University School of Medicine

Department of General Thoracic Surgery, The First Hospital of Danjiangkou City

Department of Anesthesiology, The First Hospital of Danjiangkou City

AI问答

⁰